TrialEuropean heart journal2014

The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial.

Steen Husted et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.